Showing 1741-1750 of 8179 results for "".
Dr. Joel Schlessinger discusses the importance of clinical research in your practice
https://practicaldermatology.com/topics/practice-management/dr-joel-schlessinger-discusses-the-importance-of-clinical-research-in-your-practice/19135/With hundreds of new products, procedures and technologies becoming available every day, it is important to keep up with the changing medical world. One way to do this is through clinical research at your practice. In this video, Dr. Joel Schlessinger discusses how he began his clinical research stuDermwireTV — A big name is getting bigger; ICD-10 looms
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-a-big-name-is-getting-bigger-icd-10-looms/19163/In this premiere edition of DermWireTV, from the publishers of Practical Dermatology® magazine, we take a look at the latest acquisition by Valeant Pharmaceuticals, Inc., explore new data for Galderma's Mirvaso for rosacea, and get insights on the ICD-10 code set transition. #DermWireDr. Matthias Donelan
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/scaarfx-donelan-/19250/Dr. Donelan has been treating patients with scarring following burns for more than 35 years. Although great progress has been made, he found it difficult to bring patients back to their pre-injury state. Learn about his experience with the Lumenis UltraPulse and how it has impacted patients' qualityQuantel Derma LEDA Diode Laser System - Hair Removal at the Speed of Light
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/quantel-derma-leda-diode-laser-system-hair-removal-at-the-speed-of-light/19447/LEDA is the expandable platform system for permanent hair removal at the speed of light. LEDA applies photodynamic therapy (PDT) for the treatment of acne, Psoriasis, Vitiligo & atopic dermatitis, and for gentle skin rejuvenation. The diode laser system LEDA EPI, for hair removal, has a large spThe Science of Skin: Hidradenitis Suppurativa
https://practicaldermatology.com/podcasts/the-practical-dermatology-podcast/the-science-of-skin-hidradenitis-suppurativa/56945/In an episode of The Science of Skin Podcast, Practical Dermatology Editorial Board member and Science of Skin Summit Co-founder Ted Lain, MD, MBA, FAAD, is joined by Steven Daveluy, MD, FAAD, to discuss the complicated pathophysiology of hidradenitis suppurativa and the future of treatment capabiliImplementing and Growing PDT
https://practicaldermatology.com/series/pdt-in-practice/implementing-and-growing-pdt/29783/Dr. Todd Schlesinger described how he implemented photodynamic therapy in his practice and the strategies he utilized to increase patient access to it.A New Year and New Beginnings
https://practicaldermatology.com/series/the-practical-dermatology-podcast/a-new-year-and-new-beginnings/32417/The Practical Dermatology Podcast relaunches with the latest news to start 2025 and a conversation between Chief Medical Editor Neal Bhatia, MD, FAAD, and new Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD. Dr. Bhatia and Dr. Swanson discuss the new wave of atopic dermatitis therapeuticExperts React to Latest Benzene Analysis
https://practicaldermatology.com/series/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvPractically Here
https://practicaldermatology.com/series/the-practical-dermatology-podcast/practically-here/18186/Discover the Practical Dermatology podcast, taking you into the world of dermatology care with in-depth conversations with physicians, medical aesthetics industry, and other healthcare experts.Promising New Data on Clascoterone for Androgenetic Alopecia
https://practicaldermatology.com/series/c-suite-chats/promising-new-data-on-clascoterone-for-androgenetic-alopecia/56939/Cosmo Pharmaceuticals CEO Giovanni Di Napoli discusses the challenges posed by androgenetic alopecia (AGA) and the potential impact of a clascoterone 5% topical solution based on new Phase 3 data.